The role of passive immunization in the age of SARS-CoV-2: an update

Johannes C. Fischer; Kurt Zanker; Martijn van Griensven; Marion Schneider; Detlef Kindgen-Milles; Wolfram Trudo Knoefel; Artur Lichtenberg; Balint Tamaskovics; Freddy Joel Djiepmo-Njanang; Wilfried Budach; Stefanie Corradini; Ute Ganswindt; Dieter Haeussinger; Torsten Feldt; Hubert Schelzig; Hans Bojar; Matthias Peiper; Edwin Boelke; Jan Haussmann; Christiane Matuschek

doi:10.1186/s40001-020-00414-5

The role of passive immunization in the age of SARS-CoV-2: an update

Johannes C. Fischer, Kurt Zanker, Martijn van Griensven, Marion Schneider, Detlef Kindgen-Milles, Wolfram Trudo Knoefel, Artur Lichtenberg, Balint Tamaskovics, Freddy Joel Djiepmo-Njanang, Wilfried Budach, Stefanie Corradini, Ute Ganswindt, Dieter Haeussinger, Torsten Feldt, Hubert Schelzig, Hans Bojar, Matthias Peiper, Edwin Boelke^*, Jan Haussmann, Christiane Matuschek

^*Corresponding author for this work

Research output: Contribution to journal › (Systematic) Review article › peer-review

Abstract

The rapid spread of the corona virus pandemic is an existential problem for many people in numerous countries. So far, there is no effective vaccine protection or proven therapy available against the SARS-CoV-2 virus. In this review, we describe the role of passive immunization in times of the corona virus. Passive immunization could be a bridging technology to improve the immune defense of critically ill patients until better approaches with effective medications are available.

Original language	English
Article number	16
Number of pages	6
Journal	European Journal of Medical Research
Volume	25
Issue number	1
DOIs	https://doi.org/10.1186/s40001-020-00414-5
Publication status	Published - 13 May 2020

Keywords

Bridge therapy
Convalescent plasma
Covid-19
High risk
Immunology
Intensive care unit
Respiratory failure
COVID-19

Access to Document

10.1186/s40001-020-00414-5Licence: CC BY

1 Erratum / corrigendum / retractions

Correction to:The role of passive immunization in the age of SARS-CoV-2: an update
Fischer, J. C., Zänker, K., van Griensven, M., Schneider, M., Kindgen-Milles, D., Knoefel, W. T., Lichtenberg, A., Tamaskovics, B., Djiepmo-Njanang, F. J., Budach, W., Corradini, S., Ganswindt, U., Häussinger, D., Feldt, T., Schelzig, H., Bojar, H., Peiper, M., Bölke, E., Haussmann, J. & Matuschek, C., 30 Oct 2020, In: European Journal of Medical Research. 25, 1, 2 p., 53.
Research output: Contribution to journal › Erratum / corrigendum / retractions › Academic

Open Access

Cite this

Fischer, J. C., Zanker, K., van Griensven, M., Schneider, M., Kindgen-Milles, D., Knoefel, W. T., Lichtenberg, A., Tamaskovics, B., Djiepmo-Njanang, F. J., Budach, W., Corradini, S., Ganswindt, U., Haeussinger, D., Feldt, T., Schelzig, H., Bojar, H., Peiper, M., Boelke, E., Haussmann, J., & Matuschek, C. (2020). The role of passive immunization in the age of SARS-CoV-2: an update. European Journal of Medical Research, 25(1), Article 16. https://doi.org/10.1186/s40001-020-00414-5

@article{c27f5b07f5394486879497b0fd2bc9db,

title = "The role of passive immunization in the age of SARS-CoV-2: an update",

abstract = "The rapid spread of the corona virus pandemic is an existential problem for many people in numerous countries. So far, there is no effective vaccine protection or proven therapy available against the SARS-CoV-2 virus. In this review, we describe the role of passive immunization in times of the corona virus. Passive immunization could be a bridging technology to improve the immune defense of critically ill patients until better approaches with effective medications are available.",

keywords = "Bridge therapy, Convalescent plasma, Covid-19, High risk, Immunology, Intensive care unit, Respiratory failure, COVID-19",

author = "Fischer, {Johannes C.} and Kurt Zanker and {van Griensven}, Martijn and Marion Schneider and Detlef Kindgen-Milles and Knoefel, {Wolfram Trudo} and Artur Lichtenberg and Balint Tamaskovics and Djiepmo-Njanang, {Freddy Joel} and Wilfried Budach and Stefanie Corradini and Ute Ganswindt and Dieter Haeussinger and Torsten Feldt and Hubert Schelzig and Hans Bojar and Matthias Peiper and Edwin Boelke and Jan Haussmann and Christiane Matuschek",

note = "Publisher Copyright: {\textcopyright} 2020 The Author(s).",

year = "2020",

month = may,

day = "13",

doi = "10.1186/s40001-020-00414-5",

language = "English",

volume = "25",

journal = "European Journal of Medical Research",

issn = "0949-2321",

publisher = "BioMed Central",

number = "1",

}

Fischer, JC, Zanker, K, van Griensven, M, Schneider, M, Kindgen-Milles, D, Knoefel, WT, Lichtenberg, A, Tamaskovics, B, Djiepmo-Njanang, FJ, Budach, W, Corradini, S, Ganswindt, U, Haeussinger, D, Feldt, T, Schelzig, H, Bojar, H, Peiper, M, Boelke, E, Haussmann, J & Matuschek, C 2020, 'The role of passive immunization in the age of SARS-CoV-2: an update', European Journal of Medical Research, vol. 25, no. 1, 16. https://doi.org/10.1186/s40001-020-00414-5

TY - JOUR

T1 - The role of passive immunization in the age of SARS-CoV-2

T2 - an update

AU - Fischer, Johannes C.

AU - Zanker, Kurt

AU - van Griensven, Martijn

AU - Schneider, Marion

AU - Kindgen-Milles, Detlef

AU - Knoefel, Wolfram Trudo

AU - Lichtenberg, Artur

AU - Tamaskovics, Balint

AU - Djiepmo-Njanang, Freddy Joel

AU - Budach, Wilfried

AU - Corradini, Stefanie

AU - Ganswindt, Ute

AU - Haeussinger, Dieter

AU - Feldt, Torsten

AU - Schelzig, Hubert

AU - Bojar, Hans

AU - Peiper, Matthias

AU - Boelke, Edwin

AU - Haussmann, Jan

AU - Matuschek, Christiane

PY - 2020/5/13

Y1 - 2020/5/13

N2 - The rapid spread of the corona virus pandemic is an existential problem for many people in numerous countries. So far, there is no effective vaccine protection or proven therapy available against the SARS-CoV-2 virus. In this review, we describe the role of passive immunization in times of the corona virus. Passive immunization could be a bridging technology to improve the immune defense of critically ill patients until better approaches with effective medications are available.

AB - The rapid spread of the corona virus pandemic is an existential problem for many people in numerous countries. So far, there is no effective vaccine protection or proven therapy available against the SARS-CoV-2 virus. In this review, we describe the role of passive immunization in times of the corona virus. Passive immunization could be a bridging technology to improve the immune defense of critically ill patients until better approaches with effective medications are available.

KW - Bridge therapy

KW - Convalescent plasma

KW - Covid-19

KW - High risk

KW - Immunology

KW - Intensive care unit

KW - Respiratory failure

KW - COVID-19

U2 - 10.1186/s40001-020-00414-5

DO - 10.1186/s40001-020-00414-5

M3 - (Systematic) Review article

C2 - 32404189

SN - 0949-2321

VL - 25

JO - European Journal of Medical Research

JF - European Journal of Medical Research

IS - 1

M1 - 16

ER -

The role of passive immunization in the age of SARS-CoV-2: an update

Abstract

Keywords

Access to Document

Research output

Correction to:The role of passive immunization in the age of SARS-CoV-2: an update

Cite this